Upgrade to see committee overlap, performance context, and full expert analysis.
COHR congressional trades
7 matched disclosures
COHR congressional trades snapshot
This page summarizes public STOCK Act disclosures involving COHR. It is useful for seeing which lawmakers reported COHR transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Apr 7, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the COHR congressional trade page shows
Congressional Trader tracks 7 public STOCK Act disclosures for COHRacross 3 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent COHR filing shown here was filed on Apr 7, 2026 by Gilbert Ray Cisneros as a purchase. Related lawmakers include Lisa C. McClain, Markwayne Mullin, Gilbert Ray Cisneros.
Top lawmakers for COHR
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded COHR?
Recent COHR disclosures include Lisa C. McClain, Markwayne Mullin, Gilbert Ray Cisneros.
What is the buy/sell mix for COHR?
The visible sample currently shows 5 purchases and 2 sales or partial sales.
Should I trade based on COHR disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.